Literature DB >> 7179215

Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina.

I Vlodavsky, A Eldor, E HyAm, R Atzom, Z Fuks.   

Abstract

Cultured bovine endothelial cells produce an extensive underlying extracellular matrix (ECM) which closely resemble the vascular subendothelial basal lamina in its organization and chemical composition. This naturally produced ECM was used to study the interaction of platelets with the subendothelium when exposed or covered with vascular endothelial cells. Incubation of platelet rich plasma with the ECM induced a rapid and massive platelet adherence, aggregation, thromboxane formation and release reaction. These were demonstrated using phase and scanning electron microscopy, Indium-111 or (14C)-serotonin labelled platelets, and a radioimmunoassay for thromboxane B2. In contrast to the ECM no platelet activation was induced either by uncoated plastic dishes or ECM covered with a confluent endothelial cell monolayer. Aspirinized platelets failed to undergo aggregation and degranulation, when incubated with the ECM. Culture dishes coated with characteristic constituents of the basal lamina such as collagen type IV and type V or fibronectin induced a much lower platelet reactivity as compared with ECM coated dishes. Digestion of ECM components (collagen, fibronectin, hyaluronic acid, and chondroitin sulphate) by specific enzymes was not associated with a substantial decrease in its platelet reactivity. Furthermore, exposure of ECM to sodium dodecyl sulphate or sodium periodate, or freezing and thawing did not decrease its biological activity. In contrast, platelet activation was completely abolished following heat denaturation or glutaraldehyde fixation of the ECM. The availability of a naturally produced ECM provides an appropriate model to study the interaction of platelets with the subendothelium in a controlled system which is isolated from other components of the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7179215     DOI: 10.1016/0049-3848(82)90260-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

Review 1.  Platelet function tests in the assessment of antithrombotic agents.

Authors:  M Greaves
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Impaired von Willebrand factor adhesion and platelet response in thrombospondin-2 knockout mice.

Authors:  Nina Kristofik; Nicole E Calabro; Weiming Tian; Aaron Meng; Susan MacLauchlan; Yinong Wang; Christopher K Breuer; George Tellides; Laura E Niklason; Themis R Kyriakides
Journal:  Blood       Date:  2016-07-28       Impact factor: 22.113

3.  Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.

Authors:  T H Müller; C A Su; H Weisenberger; R Brickl; G Nehmiz; W G Eisert
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

4.  Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.

Authors:  K Krupinski; M Basic-Micic; E Lindhoff; H K Breddin
Journal:  Blut       Date:  1990-11

Review 5.  The influence of biomaterials on endothelial cell thrombogenicity.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2007-02-09       Impact factor: 12.479

6.  Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.

Authors:  J Yahalom; A Eldor; Z Fuks; I Vlodavsky
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Strategies for whole lung tissue engineering.

Authors:  Elizabeth A Calle; Mahboobe Ghaedi; Sumati Sundaram; Amogh Sivarapatna; Michelle K Tseng; Laura E Niklason
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-28       Impact factor: 4.538

8.  Analysis of adherence of Streptococcus defectivus and endocarditis-associated streptococci to extracellular matrix.

Authors:  R C Tart; I van de Rijn
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus.

Authors:  J I Flock; S A Hienz; A Heimdahl; T Schennings
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy.

Authors:  W Nathaniel Brennen; Daniel L J Thorek; Wen Jiang; Timothy E Krueger; Lizamma Antony; Samuel R Denmeade; John T Isaacs
Journal:  Immunotherapy       Date:  2020-11-05       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.